Home › Type 1 Diabetes › NCT07292558
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Achieving Health in Emerging Adults With Diabetes (AHEAD) Study
Who can join
Ages 16 to 19 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. 16-19 years of age 2. Have had type 1 diabetes ≥ 12 months 3. Had a recent HbA1c ≥7.0% 4. Currently receive outpatient diabetes care at a Seattle Children's Hospital Diabetes Clinic located in Bellevue, Everett, Federal Way, or Seattle 5. Are able to complete written surveys 6. Will be able to receive clinical care in WA State for the next 2 years Exclusion Criteria: 1. Have had a pilot program AHEAD clinic visit 2. Most recent Usual Care diabetes visit was with a current AHEAD provider
About the study
The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care.
Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.
What is being tested
- AHEAD Program (behavioral)
Sponsor: University of British Columbia · Participants: 306 · Started: Dec 15, 2025
Contact the study team
- Beth Loots, MPH, MSW · Phone: 206-884-4488
- Faisal S Malik, MD, MSc · Phone: 604-875-2117
Official record on ClinicalTrials.gov — NCT07292558
Locations in the U.S.
| Washington | Seattle Children's, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.